VANCOUVER, Nov. 25, 2019 /CNW/ – Dr. M-J Milloy, the Canopy Growth Professor of Cannabis Science at the University of British Columbia (“UBC”) is proud to bring together patients and other people with lived and living experience with researchers, clinicians, and policymakers for the inaugural Cannabis Science Symposium with the goal of establishing a research agenda for cannabis and harm reduction during the overdose crisis.
The one-day public research symposium is organized by the BC Centre on Substance Use (“BCCSU”) and UBC with support from Spectrum Therapeutics, the medical division of Canopy Growth Corporation (TSX: WEED), (NYSE: CGC).
In the midst of an ongoing overdose crisis impacting communities across Canada and the United States, new measures are needed to prevent overdose-related morbidity and mortality, especially among people living with substance use disorders and common comorbidities, such as chronic pain. A growing wealth of preliminary evidence suggests cannabis might be a beneficial harm reduction-based intervention. This research symposium will gather expertise to discuss the latest evidence, reflect on the current responses to the overdose crisis, and establish next steps to advance knowledge, policy and practice around cannabis for harm reduction.
Click here to read the full story in the Cision News.
Similar story can be found in the following media outlet: CBC news.